drugset / Trial / NCT00529581
A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of C105 in treating the cognitive deficits that can occur due to multiple sclerosis.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-03
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C105 | Unknown | — | — |